| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/18/1995 | US5407671 Mixture of fibrinogen, blood coagulation factor xiii, prothrombin, antitrombin, calcium compound and aprotinin |
| 04/18/1995 | CA2015475C Treating agent for osteoarthritis |
| 04/18/1995 | CA1335286C Labile ketone derivatives of 3-substituted-1-alkylamino 2-propanols and their use as .beta.-adrenergic blockers |
| 04/18/1995 | CA1335284C Pharmaceutical product having epidermal regenerative activity based on the active ingredient of mimosa tenuiflora and process for its obtention |
| 04/16/1995 | CA2118200A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
| 04/16/1995 | CA2118188A1 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/1995 | CA2118097A1 Methods for inhibiting angiogenesis and angiogenic diseases |
| 04/16/1995 | CA2118094A1 Methods for inhibiting cartilage degradation |
| 04/16/1995 | CA2117854A1 Methods for inhibiting bone loss |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | WO1995009869A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | WO1995009866A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009865A1 Glutathione s-transferase-activated compounds |
| 04/13/1995 | WO1995009848A2 Polyazacycloalkanes as dichelants |
| 04/13/1995 | WO1995009845A1 Pyrimidinyl-glutamic acid derivatives |
| 04/13/1995 | WO1995009843A1 Hiv protease inhibitors |
| 04/13/1995 | WO1995009842A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/13/1995 | WO1995009627A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 04/13/1995 | WO1995009624A1 Compounds, compositions and treatment of allergies and inflammation |
| 04/13/1995 | WO1995009619A2 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 04/13/1995 | WO1995009614A1 Pharmaceutical composition |
| 04/13/1995 | WO1995009607A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995005167A3 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 04/13/1995 | CA2173598A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | CA2173234A1 Pyrimidinyl-glutamic acid derivatives |
| 04/13/1995 | CA2173111A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | CA2172735A1 Polyazacycloalkanes as dichelants |
| 04/13/1995 | CA2167413A1 Pharmaceutical composition |
| 04/13/1995 | CA2148361A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/13/1995 | CA2117821A1 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them |
| 04/12/1995 | EP0647636A1 Benzothiazole compound, process for producing the same, and use thereof |
| 04/12/1995 | EP0647629A1 Neurotensin active substituted 1-naphthylpyrazole-3-carboxamides, their preparation and pharmaceutical compositions containing them |
| 04/12/1995 | EP0647627A1 1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridines as angiotensin II antagonists |
| 04/12/1995 | EP0647621A1 Aryl and heterocylic cyanoguanidine derivatives |
| 04/12/1995 | EP0647450A1 Improved prodrugs for enzyme mediated activation |
| 04/12/1995 | EP0647447A1 Carbostyril derivatives as phosphodiesterase inhibitors |
| 04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
| 04/12/1995 | EP0647237A1 Double chain peptide compounds having hemoregulatory activity |
| 04/12/1995 | EP0647231A1 N-substituted 3-azabicyclo 3.2.0]heptane derivates useful as neuroleptic agents, etc. |
| 04/12/1995 | EP0487520B1 Compressed powder medicaments |
| 04/12/1995 | CN1101285A Spirit for face-skin nutrition |
| 04/12/1995 | CN1101279A Health-care medicine spirit |
| 04/12/1995 | CN1101264A Snakehead oral liquid and its process |
| 04/12/1995 | CN1101259A Novel aesculetin derivatives and pharmaceutical |
| 04/12/1995 | CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/11/1995 | US5405990 Chemical compounds |
| 04/11/1995 | US5405964 Imidazopyridines |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/11/1995 | US5405863 Antioxidant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 04/11/1995 | US5405849 Treating hypertension, congestive heart failure |
| 04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
| 04/09/1995 | CA2133804A1 1,2-dihydro-2-oxo-3-methylsulfonylaminomethylpyridines |
| 04/08/1995 | CA2132770A1 Aryl and heterocyclic cyanoguanidine derivatives |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009169A1 Process for the preparation of 9-amino camptothecin |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995009001A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172125A1 Inhibitors of farnesyl-protein transferase |
| 04/05/1995 | EP0646569A1 Novel carboxylate derivatives exhibiting phospholipase A2 inhibitory activity |
| 04/05/1995 | EP0646376A1 Immunomodulating and antiinflammatory agent |
| 04/05/1995 | EP0646127A1 Polypeptide bombesin antagonists |
| 04/05/1995 | EP0646119A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| 04/05/1995 | EP0646115A1 Heterocyclic-cyclic amine derivatives |
| 04/05/1995 | EP0646112A1 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 04/05/1995 | EP0646110A1 N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc. |
| 04/05/1995 | EP0646022A1 Prosthetic devices having enhanced osteogenic properties |
| 04/05/1995 | EP0646019A1 Pretargeting methods and compounds |
| 04/05/1995 | EP0646016A1 Synthetic peptides for the treatment of myasthenia gravis |
| 04/05/1995 | EP0646012A1 Wound healing and treatment of fibrotic disorders |
| 04/05/1995 | EP0646008A1 Minimizing progestin associated breakthrough bleeding |
| 04/05/1995 | EP0646005A1 Methods for treating arteriosclerosis |
| 04/05/1995 | EP0561948B1 Phosphonic acid derivatives useful as antiinflammatory agents |
| 04/05/1995 | EP0559756B1 Nonapeptide bombesin antagonists |
| 04/05/1995 | EP0544812B1 Bisphosphonic acid derivatives as anti-arthritic agents |
| 04/05/1995 | EP0365664B1 Use of synthetic l-carnitine in food for domestic dogs or cats |
| 04/05/1995 | CN1101047A Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
| 04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
| 04/05/1995 | CN1028103C Piperidinyl benzimidazoles |
| 04/04/1995 | US5403857 Enzyme inhibitors, antiallergens, antiinflammatory agents |
| 04/04/1995 | US5403856 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
| 04/04/1995 | US5403848 Diagnosis and treatment of a disorder of the gastrointestinal tract |
| 04/04/1995 | US5403847 Use of α1C specific compounds to treat benign prostatic hyperlasia |
| 04/04/1995 | US5403845 Muscarinic agonists |
| 04/04/1995 | US5403836 Anticoagulants |
| 04/04/1995 | US5403829 Administering to promote formation of bone tissue |
| 04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
| 04/04/1995 | US5403592 Lubricant composition for rheumatism |
| 04/04/1995 | CA1335105C 1.alpha.-hydroxyvitamin d2 epimer and derivatives |
| 04/02/1995 | CA2133115A1 Carboxylate derivatives exhibiting phospholipase a2 inhibitory activity |
| 03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
| 03/30/1995 | WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 03/30/1995 | WO1995008565A1 Use of angiotensin ii analogs in tissue repair |
| 03/30/1995 | WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics |